Researchers report on a multinational, early phase clinical trial evaluating a new targeted therapy for patients with metastatic or unresectable non-small cell lung cancer who have a specific genetic mutation: EGFR Ex20Ins.
from Latest Science News -- ScienceDaily https://ift.tt/3s48sBb
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment